WuXi Biologics’ investment in Dundalk represented a significant expansion of its global manufacturing capability and the development of its first biopharmaceutical manufacturing facility outside China. Lawler Consulting was appointed to provide Mechanical & Electrical design consultancy services, supporting the delivery of the complex building services infrastructure required for this highly technical facility.
Biopharmaceutical manufacturing places significant demands on building services design. The scale and technical requirements of the WuXi facility called for carefully coordinated mechanical and electrical infrastructure capable of supporting both the building and its specialist manufacturing operations.
Lawler Consulting’s role encompassed the design of HVAC building utility systems and public health services, alongside the electrical infrastructure required to support a complex, highly serviced facility.
Electrical resilience formed an important part of Lawler Consulting’s design remit.
Our team was involved in the design of the facility’s MV and LV electrical systems, including DRUPS, generator and UPS systems. The wider electrical design also incorporated containment, LV power, normal and task lighting, emergency lighting, ICT and ELV systems.
Together, these systems formed an integrated electrical infrastructure designed around the operational requirements of a major pharmaceutical manufacturing environment.
On a project of this scale and services complexity, coordination was fundamental.
Lawler Consulting produced LOD 400 BIM models for the systems within our design remit, enabling detailed coordination of mechanical and electrical services within the wider building design.
This detailed approach supported the integration of extensive building services across the facility while maintaining the functionality and performance demanded by the manufacturing environment.
The completed Dundalk campus has gone on to become an important part of WuXi Biologics’ international manufacturing network. The facility achieved GMP certification in 2022, and in 2025 received its first EMA approval as a commercial manufacturing site for an innovative biologic.
Lawler Consulting’s involvement demonstrates our ability to deliver coordinated M&E design and BIM expertise for large-scale, technically complex industrial and pharmaceutical environments.
From resilient M&E infrastructure to detailed BIM coordination, our team brings the technical expertise needed to support complex industrial and pharmaceutical developments.
Simply drop in your contact details and let us know a good time to reach you and one of our expert engineering team will call to discuss your needs and how we might be able to help